Author: Woodenscale AI

StrainX Bioworks is a precision fermentation startup building alternative proteins and other high-value biomolecules with engineered microbes. The Bhopal-based company has raised $13 million, or about ₹124 crore, in a round led by Prime Venture Partners and Leo Capital as it emerges from stealth. The bet is clear: India has scientific talent in abundance, but very little non-pharma fermentation infrastructure built for food-grade ingredients at commercial scale. Founded in 2023 by IIT Delhi alumni Akshay Mittal and Dr. Alok Malaviya, StrainX wants to close that gap with manufacturing in Bhopal. Its R&D is in Bengaluru.

What does the precision fermentation startup StrainX Bioworks do?

StrainX Bioworks engineers microbes to produce high-value biomolecules, then scales those organisms through precision fermentation so the output can be manufactured reliably instead of staying stuck in the lab. Its current focus is food ingredients. The platform also targets nutraceuticals, beauty, and broader non-animal biomolecules for categories like nutrition and cosmetics. The company describes the process as turning engineered microorganisms into ingredients for commercial applications.

That matters because StrainX isn’t just doing the science demo. Mittal has described it as a “full-stack approach,” and that fits here. The company handles strain engineering and fermentation. It also manages process scale-up, product development, manufacturing, and commercialization in-house rather than handing off each stage to a different partner.

For a customer, the workflow is straightforward. A brand or ingredient buyer wants a specific molecule or functionality — taste, texture, nutrition, clean-label performance, or a bioactive compound. StrainX designs microbial strains for that target, runs fermentation at scale, and works the downstream process until the ingredient hits the purity, batch size, and application needs the buyer cares about. Mittal said products can sell for anywhere from a few hundred dollars to a few thousand dollars per kilogram, depending on purity, packaging, size, and end use.

There’s also a practical angle. Old-school biotech handoffs are messy. One lab proves the molecule. Another facility tries to scale it. A third partner deals with productization. StrainX is trying to remove that friction by keeping the wet lab and fermentation know-how under one roof in India, along with its manufacturing footprint.

Who founded the precision fermentation startup StrainX Bioworks?

Founded to fix a manufacturing bottleneck

StrainX was founded in 2023 by Akshay Mittal, the company’s founder and CEO, and Alok Malaviya, its co-founder and CTO. Both are IIT Delhi alumni, and the company spent roughly the last 2 to 3 years building quietly before formally stepping out of stealth in May 2026. The thesis was simple but not easy: India had plenty of biology talent, but very limited precision fermentation infrastructure suited to food proteins and ingredients rather than pharma-style production.

Mittal brings the business side. Before StrainX, he was active as a serial entrepreneur and angel investor and was associated with First Coffee Ventures. That mix matters. Precision fermentation companies don’t fail only on science. They also fail on cost structure, partnerships, and the ugly work of getting from lab output to repeatable manufacturing.

Malaviya brings the deeper technical background. He earned a PhD in Biochemical Engineering and Biotechnology from IIT Delhi and worked across Reliance Life Sciences, KAIST, ICGEB, and DuPont India before joining Christ University in Bengaluru. His background is unusually on-point for this job: industrial biotechnology, fermentation process development, bioprocess R&D, and food, feed, and nutrition applications.

Early traction, team, and the $13M raise

This isn’t a paper company. StrainX already operates a Bhopal fermentation facility with 10,000 liters of capacity, and it has completed verified fermentation runs at that scale. The company has US clearance to commercialize its first molecule and is now working toward Indian approvals. SynBioBeta reported a more specific detail: one molecule already has US self-GRAS status.

The team is already sizable for a startup this young. StrainX has around 100 employees, with roughly one-third in the Bengaluru R&D lab and the rest in Bhopal across manufacturing, engineering, and operations. It plans to double headcount to 200 by the end of the current financial year. It also plans to expand into new science verticals.

Prime Venture Partners and Leo Capital led the funding round, with participation from Good Startup, Sparrow Capital, Sun Icon Ventures, Dholakia Ventures, and WindT Angels, which was founded by IIT Delhi alumni. Good Startup is based in Singapore and this is its first India investment. The fresh capital will expand capacity at the Bhopal biomanufacturing facility, push StrainX into commercial-scale production, and add more scientists and technical capability in Bengaluru.

How does StrainX Bioworks compare with other precision fermentation startups?

India’s precision fermentation bench is still small, so the closest comparisons are a mix of partial overlaps rather than perfect clones. String Bio, for example, has built a gas fermentation platform and sells ingredients across human nutrition and agriculture. It also targets emerging markets. Fermbox Bio is also building a synthetic biology and precision fermentation platform, but its work spans biomaterials and enzymes. It also covers industrial products and broader bio-based manufacturing. Loopworm sits in the wider alternative protein bucket too, though its model is very different — it uses silkworm-based production instead of bioreactors and is targeting proteins for feed, diagnostics, and animal health.

StrainX stands out on cost and integration. Mittal argues that manufacturing in India gives the company a pricing edge, and recent coverage says a Western company would need 3 to 4 times as much capital to build comparable infrastructure. StrainX is also more vertically integrated than a lot of biotech startups that stop at R&D and rely on outside scale-up partners. That doesn’t guarantee success. But it gives the company a cleaner shot at margins and speed if commercialization lands.

The legacy alternative is still contract manufacturing or infrastructure built for pharma. And that’s the gap StrainX is attacking. Food proteins and specialty ingredients need different downstream processing, regulatory workflows, and economics. If StrainX can make those pieces work from Bhopal instead of outsourcing them across multiple vendors, it has a real edge.

Why this precision fermentation startup funding round matters?

This round isn’t about hiring a few scientists and polishing a deck. It’s about turning a fermentation platform into commercial production. StrainX says its current 10,000-liter setup can scale 10x over the next 2 years, and the immediate use of funds is tied directly to that jump. That’s the difference between an impressive biotech story and an actual ingredient business.

It also says something about investor appetite. Prime Venture and Leo Capital aren’t backing a single-product thesis here. They’re backing a platform that already has infrastructure, a 100-person team, and regulatory progress in the US. If StrainX hits commercial output on time, this raise could look less like a startup round and more like the early financing of an Indian biomanufacturing asset.

How big is India’s bioeconomy opportunity for StrainX?

The macro case is big enough to get VCs interested. India’s bioeconomy grew from $10 billion in 2014 to $165.7 billion in 2024, contributes 4.25% to GDP, and has been expanding at a 17.9% CAGR over the last 4 years. The government’s target is $300 billion by 2030. Another important number: India’s biotech startup base has gone from around 50 a decade ago to nearly 11,000.

Policy support is getting more explicit too. On February 1, 2026, Finance Minister Nirmala Sitharaman announced Biopharma SHAKTI with a ₹10,000 crore outlay over 5 years. The programme is aimed at strengthening end-to-end biological manufacturing and research. It also targets regulatory capacity. Layer that on top of BioE3, Bio-RIDE, a single-window push for biological research, and BIRAC-backed startup support, and you can see why companies like StrainX are being built now instead of 5 years earlier.

Money is already following the category. In May 2026, Cellogen Therapeutics raised about $2 million from Kotak Alternate Asset Managers. In March 2026, probiotics maker ELMED Life Sciences raised $2.7 million in a Series A round from the NABARD-backed AgriSURE Fund. StrainX’s round is larger, but it’s part of a broader pattern: biotech in India is getting financed as industrial capacity, not just academic promise.

StrainX Bioworks still has a lot to prove. Fermentation economics can look great on slides and ugly in production. But the company already has a 10,000-liter base, a technical founder who’s spent years in industrial biotech, and investors willing to fund the hard part — scale.

Read how Yes Madam raised ₹50 Cr from Info Edge Growth Fund to scale its at-home salon and spa platform across India while investing in tech, partner networks, and customer trust.

FAQ

– What funding did StrainX Bioworks raise? 

 StrainX Bioworks raised $13 million, or roughly ₹124 crore, in May 2026. Prime Venture Partners and Leo Capital led the round, and Good Startup, Sparrow Capital, Sun Icon Ventures, Dholakia Ventures, and WindT Angels also joined.

– What does StrainX Bioworks actually make? 

 StrainX makes high-value biomolecules using synthetic biology and precision fermentation. Its current commercial focus is food ingredients. The platform also targets nutraceuticals, beauty, and other non-animal biomolecules that need reliable quality, clean-label performance, and manufacturing.

– Who are the founders of StrainX Bioworks? 

 StrainX was founded in 2023 by Akshay Mittal and Dr. Alok Malaviya, both IIT Delhi alumni. Mittal brings operating and investing experience, while Malaviya brings deep fermentation and industrial biotech credentials from roles spanning Reliance Life Sciences, DuPont India, ICGEB, and academia.

– Is precision fermentation a big market in India? 

 Yes — and the category is getting easier to take seriously. India’s bioeconomy reached $165.7 billion in 2024 and is targeted to hit $300 billion by 2030, while government policy in 2026 added a ₹10,000 crore Biopharma SHAKTI push to strengthen biological manufacturing and commercialization.

Yes Madam runs an at-home salon and spa platform that sends trained beauty professionals to customers’ homes across India. The Yes Madam funding round brings in ₹50 Cr from Info Edge Growth Fund in the startup’s first institutional raise after years of being bootstrapped and profitable. It’s chasing a simple problem: salon services at home are still a trust-and-hygiene business, and customers hate price opacity almost as much as they hate bad service. Founded in 2016 by Mayank Arya, Aditya Arya, and Akanksha Vishnoi, the company now wants this fresh capital to open more cities, improve its tech, and tighten its partner network.

What is Yes Madam and how does it work?

At a basic level, Yes Madam is a home salon booking platform. A customer enters their location on the app or website, browses available services, picks a slot, and books a beautician to come home. The platform also supports quicker bookings for urgent needs. That matters.

The service menu is broad enough to feel like a real salon, not a stripped-down doorstep version. It covers waxing, facials, clean-ups, mani-pedi, threading, body polishing, hair services, nail art, bridal packages, spa treatments, and newer categories like HydraGlo and laser treatments. And it isn’t just aimed at women — Yes Madam serves both male and female customers, with waxing and facials still acting as anchor services.

What makes the model more interesting is what it removes from the old offline salon routine. Customers don’t need to travel or wait. They also don’t have to guess what products are being used. Yes Madam separates service and product charges, uses its own mono-dose single-use packs for more transparency, and includes the usual platform basics like verified experts and secure payments. It also offers a satisfaction promise. That’s not flashy tech. In this category, boring operational trust is the product.

Who founded Yes Madam and what traction has it built?

The founding story

Yes Madam started in 2016 after a bad personal experience with home salon services. Mayank Arya and Aditya Arya built the company after a botched appointment left their wives with severe skin reactions. That pushed them toward a model built around pricing transparency and tighter product control. It also meant more accountability from service professionals. Akanksha Vishnoi later joined the founding team and took on the brand and marketing side.

Why the founders fit this category

Mayank Arya’s background is less beauty and more hard-knocks entrepreneurship. He spent his early career in the Merchant Navy, then built multiple businesses in Liberia in 2009 and became wealthy before returning to India after violence and the Ebola outbreak hit those ventures. Aditya Arya also came from the maritime world — he became a 2nd mate and, at 26, trained to become a Dynamic Positioning Officer in 2012 before leaving that track for entrepreneurship. Akanksha Vishnoi studied BBA LLB at Symbiosis Law School. She brought brand-building instinct, design sense, and marketing ownership into the company.

Traction, partner economics, and the numbers that matter

This isn’t a tiny experiment anymore. Yes Madam is active in around 55 cities, fulfills about 3 lakh bookings a month, and has completed more than 65 lakh bookings since launch. Customer retention is close to 80% and NPS is around 50, which suggests people aren’t treating it like a one-off convenience purchase. The platform also works with more than 12,000 partner professionals.

The supply side is a big part of the pitch. Yes Madam says its low-commission structure helps partners earn about ₹25,000 a month on average, with top performers making up to ₹60,000. Its official material also highlights BWSSC-certified training and insurance-related benefits. It also points to support systems for service partners. That matters because beauty-at-home platforms live or die on professional retention, not just customer acquisition.

The financial profile is what probably got investors comfortable. Yes Madam says it remained bootstrapped until now, posted a profit of ₹1.8 Cr in FY25, and lifted revenue to ₹195 Cr in FY26 from ₹94 Cr in FY25. It also said EBITDA for FY26 was expected to grow 368% year on year from ₹2.6 Cr in the previous fiscal. The company showed up on *Shark Tank India* in 2024. But this Info Edge cheque is the real institutional validation.

What the funding round looks like

The new round is ₹50 Cr, or about $5.2 Mn, from Info Edge Growth Fund. It’s the company’s maiden institutional funding round. This isn’t seed money for a still-figuring-it-out startup — it’s growth capital for a business that has already built revenue and profitability. Yes Madam says it will use the money to enter more Indian cities, improve its technology stack, deepen its professional network, and sharpen customer experience.

How does Yes Madam compare with Urban Company and Snabbit?

Urban Company is still the obvious benchmark. It’s a much broader home-services platform, covering beauty and wellness alongside cleaning, repairs, and maintenance. Yes Madam is narrower and more category-focused, which can be an advantage if execution stays tight. It doesn’t need to be everything to everyone. It just needs to be really good at beauty and wellness at home.

Then there’s the next wave of faster, more local competition. The source article names GetLook, Swagmee, and GlamCode as emerging rivals, while BilluCare has pushed into rapid-response salon delivery with service promised in roughly 30 to 45 minutes. Snabbit went one step further in May 2026 with an instant salon-at-home launch in Bengaluru after a pilot that completed more than 2,000 beauty jobs in six weeks. Average fulfilment was under 15 minutes.

Yes Madam’s answer isn’t raw speed alone. It’s trying to win on trust, partner economics, and repeatability. Inc42 reported earlier in 2026 that the company had begun shifting top performers to a 0% commission structure, leaning more on product margins and platform fees instead. Pair that with mono-dose packaging and transparent line-item pricing, and the play is clear: become the specialist brand customers trust and the platform professionals prefer.

How does Yes Madam funding change the company now?

This round matters because it changes the pace of execution, not the survival odds. Yes Madam was already profitable and had already built real scale without outside institutional capital. So the Info Edge investment looks less like a bailout and more like an accelerator for a model that’s already working.

It also gives the company room to invest in the less glamorous parts of the business. Better dispatching and better partner onboarding need capital. So do sharper customer experience and more reliable service quality across new cities. In a home-services business, the tech stack isn’t there to look clever. It’s there to reduce no-shows, improve matching, handle repeat bookings, and stop operations from turning messy as coverage expands.

There’s also a margin story underneath the salon story. Yes Madam earns from service commissions, product sales, and training fees, and it wants more of its future growth to come from private-label products and beauty devices used by professionals on the platform. If that piece scales, this stops being just a booking company and starts looking more like a services-plus-products engine. The company has also said it wants to enter GCC and Southeast Asian markets later.

How big is India’s at-home salon market getting?

The direct home-salon market is still fragmented, but the broader demand pool is large and getting larger. IMARC puts India’s beauty and personal care market at $31.19 Bn in 2025 and projects it will reach $48.72 Bn by 2034, with a 5.08% CAGR. That’s the backdrop for why investors are still paying attention to startups that can turn grooming into a repeat, app-led service.

There’s also a second trend that fits Yes Madam’s strategy neatly: beauty devices are growing faster than the wider category. IMARC estimates India’s beauty devices market reached $2.1 Bn in 2025 and could hit $7.4 Bn by 2034. That lines up with Yes Madam’s plan to grow private-label device sales, which could become a much better business than relying only on marketplace commissions.

Consumer behavior has shifted too. People are more comfortable booking services at home, more sensitive to hygiene, and less loyal to neighborhood salons if an app can give them convenience plus trust. Investors clearly see that shift — Snabbit alone raised $56 Mn in April 2026 to expand instant home services. So this category isn’t cooling off. It’s speeding up.

Yes Madam funding is interesting because it backs a category specialist at a moment when home services are splitting into two camps — broad super-apps and focused operators. The question now is whether the company can keep service quality high while adding cities, partners, and product revenue at the same time.

Read how abcoffee raised ₹61 crore in a pre-Series B led by Kliff Ventures to scale its tech-enabled grab-and-go coffee chain across Mumbai, Delhi NCR, and Bengaluru while doubling down on subscriptions, supply chain, and app-led repeat ordering.

FAQ

– What is the Yes Madam funding amount and who invested? 

 Yes Madam raised ₹50 Cr in its maiden institutional funding round from Info Edge Growth Fund. The company plans to use the capital for city expansion across India, stronger tech infrastructure, a deeper professional network, and a better customer experience.

– How does Yes Madam work for salon at home bookings? 

 Customers book through the Yes Madam app or website by entering their location, selecting a service, choosing a time slot, and confirming the appointment. The platform offers categories like waxing, facials, hair care, nail services, and spa treatments, with verified professionals visiting the customer’s home.

– Who founded Yes Madam? 

 Yes Madam was founded in 2016 by Mayank Arya, Aditya Arya, and Akanksha Vishnoi. Mayank and Aditya came from maritime careers before building the business, while Akanksha brought legal training, design instincts, and brand-building experience into the founding team.

– Is at-home salon services a big market in India? 

 Yes — and it sits inside a much larger beauty and personal care market that IMARC valued at $31.19 Bn in 2025. That market is projected to reach $48.72 Bn by 2034, and adjacent categories like beauty devices are expanding even faster, which helps explain why startups and investors keep pushing into home beauty services.

abcoffee is a Mumbai-based specialty coffee chain built around a tech-enabled grab-and-go format. The abcoffee funding round has brought in ₹61 crore in a pre-Series B led by Kliff Ventures, at a time when a lot of Indian coffee drinkers want better coffee without paying sit-down café prices or wasting 15 minutes in line. Founded in 2022 by Abhijeet Anand, the company plans to use the money to deepen its footprint in Mumbai, Delhi NCR, and Bengaluru. It also wants to put more muscle behind tech, supply chain, subscriptions, and product development.

What is abcoffee and how does it work?

abcoffee is trying to turn premium coffee into a repeat, low-friction purchase. A customer opens the app, finds a nearby store, picks a drink or food item, and checks out in a few taps. The app is built around speed — saved preferences, nearby store discovery, smart search, and a 3-tap ordering flow meant for rushed mornings, office breaks, and transit stops rather than slow café hangs.

Then there’s absub, the company’s subscription layer. Instead of one flat membership, abcoffee offers different cards for different routines, and users can track usage and balance in real time inside the app. Subscribers also get priority access to offers and new menu launches. That matters.

The more interesting piece is abcircle. That system lets customers log order IDs from multiple channels — the app, subscriptions, dine-in, and aggregator platforms like Swiggy and Zomato — and roll them into one rewards identity. That’s not a small tweak. It means abcoffee isn’t treating loyalty as an app-only feature. It’s trying to stitch together behavior from everywhere the customer buys.

Here’s what manual work this removes: a lot of the annoying bits. Less queueing and re-order friction. Less dependence on a barista remembering your usual. For the company, it creates cleaner data on frequency, channel mix, and repeat behavior. That’s exactly what a grab-and-go chain needs if it wants to scale without turning every outlet into a full café operation.

Who founded abcoffee and how far has it scaled?

The founding story

abcoffee was founded in 2022 by Abhijeet Anand in Mumbai. Anand has framed the company around one blunt question: why should a decent cup of coffee still feel like a luxury in India when the country already grows high-grade beans? That idea shows up in the brand’s core pitch — premium Indian coffee, faster format, lower price point, wider access.

Why Anand looks like a credible builder for this category

Anand didn’t come out of a traditional café chain background. He studied petroleum engineering at IIT-ISM and spent nearly a decade at Schlumberger across engineering, commercial, and people-management roles before starting abcoffee. He left a global corporate career to build the company, which fits the business better than it first appears. Compact retail formats live or die on execution and process discipline. Throughput matters too.

The traction and early signals

The company now operates more than 90 outlets across Mumbai, Delhi NCR, and Bengaluru. In FY26, revenue doubled year on year, store-level EBITDA jumped 193.2%, and about 60% of customers returned for repeat purchases. It says 54% of takeaway orders now come through the abcoffee app. The digital subscription system contributes nearly half of all app orders and pre-sells more than 40,000 cups every month.

That operating story matters more than the store count by itself. abcoffee isn’t pitching itself as a lifestyle café brand first. It’s pitching a habit business. Frequency, app ordering, and prepaid demand matter as much as footfall. The recent launch of Matcha and Procaff, its protein coffee line, fits that logic too because both push the menu toward functional, everyday consumption rather than once-in-a-while indulgence.

The fundraising details

The new round brings in ₹61 crore, or about $6.4 million, in pre-Series B funding led by Kliff Ventures. Hero Enterprise Partner Ventures, Merisis Venture Fund, and Stride Ventures also joined. With this round, abcoffee’s total funding has crossed $11 million, including its earlier $3.4 million Series A led by Nexus Venture Partners.

The money won’t just pay for new storefronts. abcoffee plans to use it for expansion across existing and new markets in Mumbai, Delhi NCR, and Bengaluru. It’s also investing in customer engagement, subscriptions, supply chain, product innovation, tech, and backend infrastructure. In plain English: it’s funding both more stores and the software-and-ops layer that keeps those stores moving.

Competition and market positioning

abcoffee is fighting on two fronts. One is specialty coffee retail, where Blue Tokai is still the obvious reference point — the company now operates more than 175 cafés and is in the middle of a ₹175 crore funding extension. The other is the newer quick-service coffee wave, where younger brands like First Coffee are also pushing single-origin Indian coffee through a faster, convenience-led format.

There are adjacent rivals too. Sleepy Owl and Country Bean helped train Indian consumers to buy premium coffee outside the traditional café visit, mostly through home and packaged formats. Nothing Before Coffee plays a broader QSR-style café game. abcoffee’s bet is narrower and sharper: compact decks and lower dwell time. It’s also built around app-led repeat ordering and pricing for frequency rather than occasion.

Why does the abcoffee funding round matter?

Because this round looks less like celebration money and more like operating capital for a format that can get complicated fast.

Store-led food and beverage expansion is expensive if every outlet needs big real estate, large crews, and long customer dwell time. abcoffee is avoiding that trap by pushing a cluster-led buildout in dense urban pockets, including office, residential, and transit-heavy micro-markets. That gives it a better shot at tighter delivery loops and better procurement planning. It also boosts brand visibility without pretending every neighborhood needs a lounge-style café.

The second reason it matters is the mix of spending priorities. If the company were only opening outlets, this would be a standard retail expansion story. But money is also going into subscriptions, backend systems, and customer-facing tech, which suggests management thinks the real moat is repeat behavior, not just store count. That’s a smarter thesis. Coffee chains get copied all the time. Habit loops are harder to copy.

Kliff Ventures also isn’t a random name on the cap table. It comes out of K Hospitality, which gives this deal a more operational flavor than a pure financial one. That doesn’t guarantee anything. But it suggests investors are backing abcoffee as a retail execution story, not just another consumer brand with nice packaging.

How big is India’s specialty coffee market?

The near-term category tailwind is real. India’s ready-to-drink coffee market generated $1.723 billion in 2024 and is projected to reach about $2.676 billion by 2030, growing at a 7.5% CAGR from 2025 to 2030. That’s smaller than the $20 billion headline figure sometimes used in broader coffee discussions, but it’s still big enough to support multiple models across café, packaged, and on-the-go consumption.

Coffee demand in India has been climbing in a more basic sense too. The Coffee Board says domestic demand rose from 84,000 tonnes in 2012 to 91,000 tonnes in 2023, driven by café culture, higher disposable incomes, and younger consumers trading up into premium and specialty offerings. It also says specialty coffee is no longer just a metro luxury. That’s a big clue about where the next leg of growth could come from.

That’s why the “third wave” framing around Indian coffee doesn’t feel like empty marketing. Consumers are learning to care about origin, brew style, and quality. At the same time, they also want convenience, better prices, and formats that fit office commutes and everyday routines. That split creates room for chains like abcoffee, which don’t need to look like legacy coffeehouses to build a serious business.

What should you watch after the abcoffee funding round?

Watch execution, not the headline number.

The next real test is whether abcoffee can keep its format sharp as it densifies Mumbai, Delhi NCR, and Bengaluru. Not just more outlets. Better micro-market selection, faster throughput, cleaner supply chains, and menu innovation that actually lifts repeat usage. If that holds, the company starts to look less like a trendy coffee startup and more like a disciplined urban retail machine.

Also watch the category pressure. Blue Tokai is scaling. Newer grab-and-go chains are showing up. Home-first specialty brands still shape consumer taste. So the abcoffee funding round only matters if the company can turn its app, subscriptions, and compact store model into something customers use almost automatically.

Read how Titan Capital launched Future Indicorns: Request for Startups – Business AI, a new initiative aimed at discovering and backing ambitious early-stage AI startups building the next generation of business software in India.

FAQ

– What is the latest abcoffee funding round? 

 The latest abcoffee funding round is a ₹61 crore pre-Series B led by Kliff Ventures. Hero Enterprise Partner Ventures, Merisis Venture Fund, and Stride Ventures also participated, and the capital will support expansion plus deeper investment in technology and operations.

– How does abcoffee work for customers? 

 abcoffee works like a fast coffee QSR with a strong app layer. Customers can find a nearby outlet and place an order in a few taps. They can also use subscription cards through absub and connect purchases from multiple channels into one rewards identity through abcircle.

– Who is Abhijeet Anand, the founder of abcoffee? 

 Abhijeet Anand is the founder and CEO of abcoffee, which he started in 2022. Before that, he studied at IIT-ISM and spent close to 10 years at Schlumberger in engineering and management roles, which helps explain the company’s process-heavy, efficiency-first operating style.

– Is abcoffee a café brand or a quick-service coffee chain? 

 It’s closer to a quick-service coffee chain than a traditional sit-down café brand. The company uses compact, high-efficiency formats and leans hard on mobile ordering, subscriptions, and repeat consumption, which puts it in a different lane from slower café-first players.

Quartermaster builds maritime intelligence hardware and software that turns working vessels into real-time sensing nodes. On May 20, 2026, the Arlington, Virginia startup said it raised a $43 million Series A co-led by First Round Capital and Quiet Capital. The pitch is pretty blunt: oceans are huge, shipping still runs on incomplete visibility, and the legacy tracking layer many operators rely on can be spoofed or simply switched off. CEO Neil Sobin founded Quartermaster in 2023, and CTO Zachary Rubin leads the technical side of SmartMast, the company’s mast-mounted sensing system.

What is Quartermaster’s maritime intelligence system?

SmartMast is a weather-hardened hardware package that mounts on a vessel’s mast or superstructure and turns that ship into a node in Quartermaster’s maritime intelligence network. It works on vessels larger than 20 gross tons. The system combines cameras, radios, onboard compute, power, satellite communications, and a display. For the operator, the workflow is simple: install the kit, collect visual and signal data at sea, process part of it onboard, then push near-real-time outputs into Quartermaster’s dashboard and alerting layer.

The sensor stack is more detailed than the source article alone suggested. SmartMast uses optical and infrared cameras with 360° rotation and 31x zoom. It also has dual software-defined radios that can capture AIS, ADS-B, VHF voice traffic, and radar signals. Quartermaster says its onboard AI detects and categorizes vessels. It tracks movement and flags behavior patterns before transmitting data globally in under 5 seconds through satellite connectivity.

That matters because the product isn’t just a camera on a pole. It’s designed to create verified intelligence. Quartermaster authenticates location data and preserves high-quality video so operators can move from a blurry hint to something closer to evidentiary-grade documentation. On the customer side, that means coast guards, navies, insurers, and researchers get a live operational picture instead of waiting for delayed or self-reported vessel signals.

Host vessels get something back, too. Quartermaster’s mariner program includes free installation that takes only a few hours. It also includes up to 60GB per month of onboard connectivity, real-time safety notifications on an onboard display, and 24/7 support through the SmartMast app. That’s a clever twist. A lot of maritime hardware startups try to sell a pricey box to a low-margin operator. Quartermaster is trying to make participation feel useful on day 1.

Who founded Quartermaster and how is it positioned in maritime intelligence?

Founding story and market fit

Quartermaster was started by Neil Sobin, who saw a gap between how much AI depends on data and how little real-time ocean data exists. Sobin came in with a background in mapping, edge data, and AI. His LinkedIn profile fills in the missing context: before Quartermaster, he worked at Hivemapper and Scale AI. Those are two very different companies, but both revolve around building valuable systems on top of large, distributed data collection.

The founding logic is easy to understand. Hivemapper showed that you can use an existing moving fleet to collect coverage. Scale AI showed what happens when strong models finally get strong data underneath them. Sobin has described the ocean as a place that hasn’t had its AI moment because it hasn’t had its data moment yet. That’s not just startup poetry. It’s the company’s whole architecture.

Rubin, Quartermaster’s CTO, brings a more technical operator profile. He has experience across maritime tech, AI, robotics, software, and startups. Sobin has spent 12 years launching technology products tied to national security problems, which helps explain why Quartermaster’s customer set already spans commercial operators and government-adjacent use cases.

Early traction and the Series A

Quartermaster isn’t pre-product. SmartMast is live, and more than 600 vessels are active across 25 countries and 4 continents. Those vessels have covered more than 10 million square miles of ocean, including 2.8 million square miles in April alone. The network has assisted in more than 20 rescues of mariners at sea. LinkedIn lists the company at 51-200 employees. This isn’t a tiny lab project anymore.

First Round Capital and Quiet Capital co-led the $43 million Series A, with participation from TMV, Steel Atlas, BoxGroup, Operator Partners, Shorewind Capital, and David Adelman. Sobin said a large share of the capital will go toward hiring engineers, especially to push computer vision and edge AI deeper into the platform. He’s argued that the ocean still has a lot of “low-hanging fruit” in computer vision. In a sector this under-instrumented, that sounds right.

Competition, incumbents, and the real wedge

The obvious incumbent is AIS, the Automatic Identification System. Sobin’s view of it is harsh: AIS is “completely broken.” His complaint is that it’s opt-in and self-reported. It’s also easy to spoof and easy to disable if a vessel wants to disappear, whether that’s for smuggling, sanctions evasion, or something smaller and less dramatic.

Direct startup competition is more fragmented. Orca AI focuses on AI-assisted navigation and situational awareness onboard ships, using computer vision to help crews avoid hazards and support autonomy. Starboard Maritime Intelligence sits closer to the government intelligence side. It fuses AIS, satellite imagery, radar, and other feeds into a maritime domain awareness platform. Saildrone is adjacent, but it uses unmanned surface vehicles rather than commercial fleets as the sensing layer.

Quartermaster’s wedge is different from all 3. It isn’t just shipboard safety software, and it isn’t purely a fusion layer sitting above other datasets. It’s building the data collection network itself by piggybacking on vessels already moving through the places where coverage matters. That’s why Bill Trenchard’s backing matters. His argument is basically that bespoke maritime hardware doesn’t scale across a planet that is mostly water, but a distributed commercial fleet might.

Why this $43M Series A matters

This round matters because Quartermaster’s value gets stronger as the network gets denser. More nodes mean more imagery and more signal data. They also mean more edge cases and better models. That can feed several businesses at once — maritime surveillance, insurance risk, safety alerts, government monitoring, and training data for marine autonomy companies — without Quartermaster having to reinvent the core sensing layer each time.

It also helps explain why investors were willing to write a big early-stage check. Quartermaster isn’t pitching one app. It’s pitching infrastructure. If the company becomes the default way to collect trustworthy, real-time surface-level ocean data, every higher-level workflow built on top of that data gets more valuable. That’s a much better story than “we make another dashboard.”

There’s a second signal here. Defense-adjacent deep tech keeps attracting capital, but investors are getting pickier about whether the underlying system can scale outside a pilot. Quartermaster’s pro-mariner model — install fast, deliver connectivity and safety value back to the crew, and build the network through participation — is probably what made the round feel credible instead of theoretical.

Why are investors betting on maritime intelligence now?

The market timing isn’t random. Grand View Research estimates the global maritime surveillance market was worth $24.3 billion in 2024 and projects it will reach $35.83 billion by 2030, a 6.9% CAGR. A separate 2026 maritime analytics estimate puts that market at $1.62 billion this year, growing to $2.59 billion by 2031. That split is useful. One market is about sensing and security. The other is about what operators can do with all that data once it exists.

The industry trend underneath both numbers is the same. Fleet digitization is moving from pilot projects to fleet-wide deployment. Satellite connectivity is getting good enough for near-real-time workflows, and operators now expect edge computing to do part of the analysis onboard instead of sending everything ashore first. At the same time, regulators, navies, insurers, and commercial fleets all want better visibility into sanctions risk, illegal activity, collision threats, and emissions-related operations. That pushes maritime intelligence from “nice to have” into core infrastructure.

What should customers watch next?

Quartermaster still has a lot to prove. Hardware breaks. Vessel partners churn. Turning broad utility into durable software-and-data revenue is never automatic.

But the basic maritime intelligence thesis is sharp: fix the ocean’s data layer first, then sell better decisions on top of it. The next milestone to watch is whether Quartermaster can turn 600+ participating vessels into a network that customers treat as essential, not experimental.

Read how Mythik raised an additional $5M to turn Eastern mythology, history, and folktales into global digital franchises built for mobile-first audiences and modern storytelling platforms.

FAQ

– What funding did Quartermaster raise?  

 Quartermaster raised a $43 million Series A announced on May 20, 2026. First Round Capital and Quiet Capital co-led the round, and the syndicate also included TMV, Steel Atlas, BoxGroup, Operator Partners, Shorewind Capital, and David Adelman.

– How does SmartMast work on a ship?  

 SmartMast is a mast-mounted package that combines cameras, radios, onboard computing, power, satellite communications, and a display. It uses optical and infrared imaging and captures multiple signal types including AIS and VHF. It runs onboard AI to classify vessel activity and can transmit outputs in under 5 seconds.

– Who is Quartermaster founder Neil Sobin?  

 Neil Sobin is Quartermaster’s founder and CEO, and he has spent 12 years building technology products for national security use cases. Before Quartermaster, his public profile shows experience at Hivemapper and Scale AI, which lines up closely with Quartermaster’s mix of distributed sensing and AI data infrastructure.

– Is Quartermaster a maritime surveillance company or an autonomy startup?  

 It’s closer to a maritime intelligence infrastructure company than a pure autonomy startup. Quartermaster’s network can support coast guards, insurers, researchers, and marine autonomy developers, but its core product is the sensing and analysis layer that makes those downstream uses possible.

Mythik is a tech-first entertainment startup turning Eastern mythology, history, and folktales into global digital franchises. The latest Mythik funding update is an additional $5 million, adding fresh momentum to a company trying to package culturally rooted stories for modern, mobile-first audiences. Founded in April 2025 by Jason Kothari, Mythik is betting that Eastern stories have huge global appeal but still lack a scaled, digital-first entertainment company built around them.

What is Mythik and how does it work?

Right now, Mythik looks less like a finished streaming platform and more like an IP engine in public. Its website already showcases mythology-led video storytelling, with titles such as Ram vs Rava, Shakuni’s story, Buddha’s first sermon, Women of Ramayana, and Bhishm’s Vow, distributed through its own site alongside YouTube and Instagram. That matters. It shows Mythik is already testing story packaging and character hooks. Audience response is part of that too.

The broader pitch is bigger than those early clips. Mythik wants to use technology across the business to bring Eastern mythology, history, and folktales to a worldwide audience and build what it openly calls a “Disney from the East.” That suggests a model built around creating original IP, then extending it across multiple formats over time. Short-form comes first. Larger franchises come later.

For a user, the experience today is simple. You arrive, watch bite-size mythology content, and get a modern retelling of familiar stories without the commitment of a full TV series or a dense book. Mythik is trying to remove the old studio formula: long development cycles and format silos. It’s also pushing back on the idea that culturally specific stories can only travel through film or television.

Who is behind Mythik funding and what has Jason Kothari built before?

The founding story

Mythik launched in April 2025 as a new entertainment-tech venture rooted in India, with a Dubai headquarters and a Mumbai office. From day 1, the company’s pitch has been consistent: take Eastern mythology, history, and folktales — stories with a built-in audience of 3.5 billion people — and rebuild them for a global audience using modern technology and distribution.

Why Kothari fits this category

Jason Kothari isn’t a first-time founder trying entertainment on a whim. While studying at Wharton, he acquired bankrupt comic-book publisher Valiant Entertainment, became CEO at 24, led its turnaround, and later sold it to DMG Entertainment in a deal valued at $100 million. He also served as executive producer on Bloodshot, the Sony Pictures film based on a Valiant character. That background matters here. Mythik is basically an IP-and-distribution bet, and Kothari has already built around characters and licensing. Story-world expansion is familiar territory.

His India operating record is different, but still relevant. Kothari later became CEO of Housing.com, moved into leadership roles at Snapdeal and FreeCharge, and worked on turnarounds rather than easy growth stories. Housing’s revenue grew 4x while expenses dropped 70% during his time there, and FreeCharge was later sold to Axis Bank. So Mythik isn’t being led by a pure creative founder. It’s being led by someone who’s spent years fixing businesses, raising money, and understanding scale.

Early signals around Mythik

The company’s bench is unusually heavyweight for something this young. Mythik says its founding team includes former senior leaders from Disney, Netflix, Amazon Studios, Jio, and Tencent. It also built a global advisory board that includes Alok Sama of SoftBank, Crunchyroll co-founder Kun Gao, former Disney strategy executive Nick Van Dyk, former Marvel COO Bill Jemas, former Amazon Studios production head John Lynch, and former Marvel and Dapper Labs technology executive Gui Karyo. For an early-stage company, that’s not normal. It tells you Mythik wants to build a full-stack entertainment company, not just a content app.

How Mythik funding was structured

This new round adds $5 million at a valuation of more than $50 million. New investors include Harsh Jain of Dream11, Rajat Gupta, Zubin Bharti Mittal, Ishan Sinha of Point72, Blume Founder’s Fund, and Rooshabh Shah. Existing investors who also participated include Sakal Media Group led by Abhijit Pawar, Jason Kothari, Anirudh Patni, Samarth Parekh, and Samir Vora. The company had already raised $15 million in seed funding in May 2025, a round that included investors such as Sakal Media Group, BITKRAFT Ventures, VC Grid, Visceral Capital, and Shah Rukh Khan’s family office.

Kothari said: “We are pleased to welcome a new group of exceptional investors who bring global perspective, networks and strategic value, as well as deepen our partnership with existing investors. This continued support reinforces our vision to build a category-defining tech-first global entertainment company, rooted in the rich storytelling of Eastern mythology, folktales and history.”

How Mythik compares with other digital storytelling bets

Mythik doesn’t sit neatly beside a single rival. The closest newer comparison set is digital-native story companies such as Toonsutra in webtoons, Pocket Entertainment’s Pocket Toons in AI-powered comics, Kuku in AI-led audio and storytelling, and Dashverse, which spans mobile comics, AI tools, and micro-drama apps. But Mythik’s positioning is broader than any one format. It’s not pitching itself as just comics or just audio. It isn’t just short drama either. It’s pitching itself as an IP company built from Eastern stories outward.

That’s also where the risk is. Broad ambition sounds great in seed decks. Execution is harder. Legacy alternatives — TV mythological serials, children’s comics, film studios, and publisher-owned character universes — may be old-school, but they already own audience habit. Mythik’s edge has to be speed and format flexibility. It also needs globally legible storytelling, not nostalgia alone.

What does Mythik funding change for the company?

This round matters because Mythik is still early enough that capital changes the shape of the company, not just the pace. The earlier seed round was about launch credibility. This $5 million extension looks more like a vote to keep building out original content and production capability. Creative and technical hiring are part of that too.

And the investor mix is telling. Dream11’s Harsh Jain brings mass consumer internet instincts. Ishan Sinha adds a public-markets and private-investing lens from Point72. Blume’s Founder’s Fund brings venture pattern recognition. Existing backers such as Sakal Media Group keep the media relationship angle alive. So this isn’t just money. It’s a cap table built around audience and distribution. Strategic judgment and access come with it too.

For customers — or really, future viewers and fans — the practical takeaway is simple: Mythik now has more room to test whether Eastern mythology can be turned into durable IP instead of one-off viral content. That’s the whole bet. If the company can move from short digital storytelling into repeatable franchises, the upside is big. If it can’t, it risks becoming another stylish mythology brand without staying power.

How big is the market behind Mythik funding?

The macro setup is real. India’s media and entertainment sector grew 9% year over year to ₹2.78 lakh crore, or $32.1 billion, in 2025, and IBEF says it could reach ₹3.3 lakh crore, or $37.9 billion, by 2028. Digital media has already crossed ₹1 lakh crore in revenue, and digital ads alone contributed ₹94,700 crore in 2025. That’s the kind of market where a new content company can be born digital instead of treating digital as a side channel.

The language tailwind is just as important. IAMAI’s ICUBE 2024 data shows 870 million internet users accessed the internet in Indic languages in 2024, and 57% of users in urban India said they prefer internet content in Indic languages. Video is the top activity in that cohort. If you’re building mythology-led entertainment with multilingual potential, those numbers aren’t background noise. They’re the demand signal.

The format side is moving too. India’s animation market was valued at $2.4 billion in 2024 and is projected to reach $14.69 billion by 2030, while PwC expects the global entertainment and media industry to hit $3.5 trillion by 2029. PwC also flags India as one of the faster-growing E&M markets, helped by internet advertising growth, 5G expansion, and short-form video behavior. That doesn’t guarantee Mythik wins.

Mythik funding is interesting because it’s not just another startup round attached to a vague AI story. It’s a specific wager that Eastern stories can travel globally if they’re rebuilt for modern formats, faster production loops, and digital-native distribution. The next thing to watch is whether Mythik stays in the short-form testing phase or starts revealing the larger franchises this cap table is funding.

Read how Piper Serica launched Bharat Tech Fund with an ₹800 crore target to back Indian deeptech startups building in AI, semiconductors, space, defence technology, and biosciences with larger Series A and B cheques.

FAQ about Mythik funding

– What is the latest Mythik funding round?  

 Mythik has raised an additional $5 million at a valuation of more than $50 million. The round was announced on May 20, 2026, and came after the company’s $15 million seed financing in May 2025.

– How does Mythik work today?  

 Today, Mythik works as an early-stage digital storytelling and IP platform built around Eastern mythology, history, and folktales. Its public-facing product already includes short mythology-led video content on its website and social channels. That suggests the company is testing characters and formats before expanding into bigger franchise plays.

– Who founded Mythik and what is Jason Kothari known for?  

 Jason Kothari founded Mythik in April 2025. He’s best known for acquiring and reviving Valiant Entertainment while at Wharton, later selling it for $100 million, and for taking senior operating roles at Housing.com, Snapdeal, and FreeCharge.

– What market category is Mythik actually in?  

 Mythik sits at the intersection of media tech and digital storytelling. It’s also an IP-led entertainment company. It overlaps with webtoon, mobile comics, micro-drama, and mythology-content startups, but its stated ambition is broader: to build globally scalable entertainment franchises from Eastern stories rather than operate as a single-format app.

Bharat Tech Fund is Piper Serica’s new growth-stage vehicle for Indian deeptech startups.

The Mumbai-based asset manager has launched the fund with a target corpus of ₹800 crore, made up of a ₹600 crore primary raise and a ₹200 crore green shoe option, at a time when a lot of IP-led startups in India still struggle to find investors comfortable with hard tech, longer R&D cycles, and bigger Series A and B rounds. Piper Serica, founded in 2004 by Abhay Agarwal, will focus the fund on companies building in semiconductors, AI, space and defence technology, fintech infrastructure, and biosciences. Ajay Modi, director at Piper Serica, is one of the public faces of that thesis.

What is Bharat Tech Fund and how will it work?

Bharat Tech Fund is a Category II AIF built to back Indian startups at the Series A and Series B stage, with cheque sizes of ₹25-50 crore. That’s a meaningful jump from seed-style capital. It puts the fund in the part of the market where deeptech companies usually need money for pilots, product hardening, certifications, and sales hiring. In some cases, they also need early manufacturing or deployment capacity.

The investing process is part software and part ground work. Piper Serica uses a proprietary AI tool called Yoda.ai to screen opportunities, then adds direct diligence through researchers, founders, academic networks, and government-linked innovation channels. The firm is already active around IIT Madras, IIT Delhi, IIT Bombay, IISc Bengaluru, and programs tied to iDEX, IN-SPACe, and DRDO.

For founders, that changes the pitch. Instead of explaining a semiconductor, defence, or space stack to a generalist investor who may not underwrite long product cycles, they’re pitching a manager that has chosen those cycles on purpose. Piper Serica is also setting an aggressive goal here — a gross IRR of 30% over 6 years. This isn’t meant to be a patient-but-modest outcome fund. It wants venture-style upside.

Who is behind Bharat Tech Fund at Piper Serica?

How Piper Serica got here

Piper Serica didn’t start as a startup investor. It began as a Mumbai-based asset management firm focused across public and private markets, and it has grown to more than ₹1,400 crore in assets under management. The startup push came later.

The firm started backing startups in 2022 through a Category I AIF aimed at early-stage companies. That first pool targeted sectors a lot of Indian generalist funds have historically treated carefully — semiconductors, AI, spacetech, defence technology, biosciences, and fintech infrastructure. Bharat Tech Fund is the next step. Same broad conviction. Much larger cheques.

Why the leadership fits this thesis

Piper Serica was founded by Abhay Agarwal, who came into the business after investment roles at Citibank India and JP Morgan’s private equity group in India. That matters because Bharat Tech Fund isn’t being run like a fresh first-time VC experiment. It’s being built by a manager that already knows how institutional capital behaves and how portfolio construction changes when the holding period gets longer and the underwriting gets tougher.

Ajay Modi brings the sector-facing edge. He’s an engineer by training and has become the clearest voice for Piper Serica’s deeptech argument — that India is shifting from consumption-led startup stories to capability-led ones. The wider leadership team has experience across firms including JP Morgan, Citibank, SBI Mutual Fund and Reuters. That gives Piper Serica a more traditional investing spine than many younger venture outfits.

What the first fund already proved

This new Bharat Tech Fund isn’t arriving with a blank sheet. Piper Serica has made 35 investments so far through its earlier startup vehicle. And the firm isn’t just pointing to activity. It’s pointing to outcomes.

Within 3 years, that first fund recorded 2 exits. One of them was a partial exit in Alt Mobility at roughly 10.2x. It has also participated in 8 follow-on rounds, while 14 portfolio companies have gone on to raise their next institutional round. That’s not a full proof point yet. Deeptech exits take time.

Modi’s thesis is blunt and clear: “For the first time, Indian founders are building IP-led, engineering-first businesses that are globally competitive, not just domestically relevant.” That line explains why Piper Serica is willing to move up the round ladder. If the founders are stronger and the tech is more defensible, the next bottleneck isn’t talent. It’s growth capital.

How Bharat Tech Fund compares with other India deeptech funds

This is where things get interesting.

India already has specialist deeptech investors. Speciale Invest has built a name in early deeptech and sovereign-tech bets. YourNest has spent years focusing on pre-Series A deeptech. pi Ventures has long backed AI and deeptech at early stages. Navam Capital and Unicorn India Ventures have also raised newer vehicles aimed at semiconductors, space, robotics, AI infrastructure, and other IP-heavy areas.

But Bharat Tech Fund is trying to sit a little differently. A lot of those rivals are most active at seed or very early institutional entry. Piper Serica is pushing harder into Series A and B with ₹25-50 crore cheques. That’s a useful slot if you believe India has already done enough on startup creation and now needs more conviction capital for commercialization.

The old alternative for many founders in this bracket has been messy — a mix of smaller VC checks, strategic investors, family offices, or generalist funds that like the story but hesitate at hardware timelines. Piper Serica’s edge, if it works, is that it wants to be the investor already comfortable with those constraints.

Why does Bharat Tech Fund matter for Indian founders?

The simple answer is cheque size.

A founder building in chips, aerospace, defence systems, or industrial AI usually doesn’t need just another seed extension. They need a round large enough to support long sales cycles, deeper engineering benches, testing, and often a second or third version of the product before scale kicks in. Bharat Tech Fund is designed for that phase.

It also matters because Piper Serica is moving from scouting to conviction. Launching an early-stage fund is one thing. Launching a larger Bharat Tech Fund after 35 bets, 2 exits, and several follow-ons says the firm thinks it has seen enough signal to write bigger tickets. That’s a more serious commitment than generic deeptech enthusiasm.

But let’s not pretend the target is conservative. A 30% gross IRR over 6 years is ambitious in any venture strategy, especially in sectors where commercialization can slip by quarters or years. Piper Serica is saying Indian deeptech is mature enough for that return profile. The next few investments will show whether that confidence is earned or just nicely packaged.

How big is India’s deeptech market for Bharat Tech Fund?

India’s timing here isn’t random.

In 2025, Indian tech startups raised $9.1 billion, up 23% year on year. Deeptech alone pulled in $2.3 billion, a 37% jump, and the country now has more than 4,200 deeptech startups, including 550-plus founded in 2025. That’s the strongest factual case for why a fund like Bharat Tech Fund can exist at this size.

There’s another important number buried in that broader shift. About 74% of total deal activity still sits in seed and early-stage rounds, while the seed-to-Series A jump remains the biggest progression gap in the market. That gap is exactly where Bharat Tech Fund wants to operate.

Sector trends also line up with Piper Serica’s shortlist. AI is swallowing a huge share of deeptech capital, while semiconductors, defence, and spacetech are getting more policy support and more founder attention than they did a few years ago. India’s startup market still has plenty of consumer and software energy, sure. But more investors now want companies with real IP, not just fast distribution.

What to watch next for Bharat Tech Fund

Bharat Tech Fund is really a bet on one idea: that Indian deeptech has moved past the stage where specialist capital can stay tiny.

Piper Serica has the early signals, a recognizable thesis, and enough prior portfolio history to justify trying. What matters now is execution — first close, first few Series A and B deals, and whether those larger cheques go into companies that can turn engineering depth into real revenue. If that starts happening consistently, Bharat Tech Fund won’t look like a niche launch. It’ll look early.

Read how Oister Global launched ACE Fund III with a ₹500 crore target to buy existing stakes in late-stage Indian startups and bring more liquidity to India’s growing private-market ecosystem.

FAQ

– What is the size of Bharat Tech Fund? 

 Bharat Tech Fund is targeting ₹800 crore in total. That includes a ₹600 crore primary raise and a ₹200 crore green shoe option, and it has been launched as a Category II Alternative Investment Fund.

– How does Bharat Tech Fund work for startups? 

 Bharat Tech Fund is built for Series A and Series B startups and plans to invest ₹25-50 crore per company. Piper Serica uses its internal Yoda.ai screening tool and then does deeper diligence through founder networks, research institutions, and government-linked innovation channels before making a bet.

– Who founded Piper Serica? 

 Piper Serica was founded in Mumbai in 2004 by Abhay Agarwal. Before starting the firm, he worked in investing roles at Citibank India and JP Morgan’s private equity group, while Ajay Modi now helps shape and articulate the firm’s deeptech investment strategy.

– Why are investors launching more India deeptech funds now? 

 Because the market finally has enough scale to justify them. India had more than 4,200 deeptech startups and $2.3 billion in deeptech funding in 2025, but a lot of that market still needs stronger Series A and B support for companies in semiconductors, AI, defence, space, and biosciences.

Oister Global runs private-market funds that buy existing stakes in late-stage Indian startups, and it has now launched ACE Fund III with a target corpus of ₹500 crore, including a ₹250 crore greenshoe option. That matters because India has built a lot of startup wealth on paper, but actual liquidity between early funding rounds and public listings is still patchy. Founded in 2022 by Rohit Bhayana and Sandeep Sinha, the Gurgaon-based firm is betting that secondaries won’t stay a niche corner of venture finance much longer.

And this isn’t Oister’s first swing. Demand for its earlier vehicles was strong enough to justify a third dedicated fund, with domestic investors doing most of the heavy lifting.

What is ACE Fund III and how does it work?

ACE Fund III is a late-stage startup secondaries vehicle. Instead of writing fresh primary cheques into a company’s balance sheet, Oister buys existing shares from people who already hold them — founders, employees, early investors, or funds that want an exit before an IPO or strategic sale.

That changes the transaction in an important way. The company being bought into doesn’t necessarily raise new money. What changes is the shareholder base. Sellers get liquidity. The cap table gets cleaned up. A new investor gets exposure to a business that’s already operating at scale and is closer to a clear exit event.

Oister’s pitch to buyers is straightforward. It wants to invest in high-growth, late-stage companies that are profitable or near-profitable and have visible routes to liquidity through IPOs, strategic exits, or later funding rounds. The firm frames secondaries as a way to enter late but still get in early enough to capture value creation before a public-market or acquisition event resets pricing.

For investors, the structure is closer to curated access than a total black box. Oister has described its approach as giving backers directional visibility into the kind of businesses it intends to buy, while using an institutional six-step underwriting process to screen deals. In plain English: it’s trying to remove a lot of the messy manual work that usually comes with off-market stake transfers. That includes sourcing sellers and pricing private shares. It also means running diligence and figuring out whether there’s a real exit path or just a nice story.

Who founded Oister Global and how is it positioned?

The founding story

Oister Global was founded in 2022 by Rohit Bhayana and Sandeep Sinha. The firm was built on the investing base of Lumis, the platform both founders had already spent years building in India’s private markets. That part matters. Oister didn’t pop up as a first-time fund manager trying to surf a trend. It came out of an existing network of founders, GPs, family offices, and private-market relationships.

The strategy also makes sense in the context of where the Indian market is now. There are more mature startups. There are more long holding periods. And there’s more pressure on early backers to return capital.

Why the founders have market fit

Bhayana and Sinha aren’t career newsletter people pretending to be allocators. Bhayana earlier served as CEO of GE Software Solutions and has spent years investing and building through Lumis. Sinha’s background includes leadership at 3Com Technologies and the global technology leadership program at GE. Between them, they bring operator experience and long exposure to private-market dealmaking. That matters here.

Their wider investing track record is one of Oister’s biggest credibility signals. Across their broader careers, the founders have deployed more than $700 million across asset classes, launched 9+ funds, and backed 100+ portfolio companies. That doesn’t guarantee returns. But it does explain why Oister can show up as a buyer in sensitive secondary transactions where sellers care about confidentiality, speed, and cap-table fit.

What Oister has already done

Oister’s secondaries franchise has already invested in startups including BlackBuck, Servify, M1xchange, Kuku, and Purplle. Across the broader secondaries book, it has also backed names such as OfBusiness, Shiprocket, and BlueStone.

Half of ACE Fund I’s portfolio companies have already reached public-market outcomes through listings, DRHP filings, or exits. Those portfolio companies posted 32% year-on-year revenue growth and a 54% expansion in margins. Those are the numbers Oister wants prospective investors to focus on: not just liquidity, but liquidity into businesses that still look operationally healthy.

The fundraising details behind the new vehicle

The immediate headline is simple: ACE Fund III is targeting ₹500 crore, and that figure includes a ₹250 crore greenshoe option. The launch follows ACE Fund II, which was oversubscribed 2x and closed at ₹400 crore against its original target.

That takes total capital committed across the ACE franchise past ₹1,000 crore. Oister has also said that nearly 98% of the capital raised across the ACE series has come from domestic investors. That’s much higher than the average mix across India’s wider alternative investment fund market.

How Oister compares with other secondaries funds

This category is getting crowded, but not evenly crowded.

The most obvious large-format rival is 360 ONE Asset, which launched a much bigger ₹4,000 crore secondary fund to buy existing stakes from investors seeking liquidity. International specialists have also been active in India-focused secondaries, including TR Capital, Foundation Private Equity, and NewQuest Capital. So Oister isn’t alone in spotting the trade.

Its differentiation is narrower and more credible because of that. Oister is focused on late-stage private companies rather than trying to be everything to everyone across secondaries. It’s also focused on domestic capital and curated deal selection. Startup-specific cap-table situations, where timing matters a lot, are central to the pitch. Against legacy alternatives — waiting for an IPO, forcing a strategic sale, or arranging one-off off-market stake transfers through brokers — that’s a cleaner product.

Why ACE Fund III matters for startup liquidity

This third fund matters because it turns a one-off market need into a repeatable product. Founders and early investors in India have been stuck in an awkward middle zone for years: too mature for early-stage narratives, not always ready for the public market, and still carrying cap tables shaped by old rounds.

A dedicated secondaries pool gives them another option. Not emergency money. Not a down-round workaround. Just structured liquidity.

That can change behavior inside companies. Employees can sell some stock before an IPO. Seed and Series A funds can return capital without waiting forever. Founders can tidy up ownership without opening a fresh primary round they may not need. Newer investors get into a proven business with more operating history and a shorter route to exit than a typical early-stage bet.

Bhayana’s broader thesis is that secondaries in India are becoming an institutional-grade strategy, not just a liquidity side hustle. If he’s right, this launch won’t be remembered as just another fund close. It’ll look more like a sign that India’s private markets are finally building a real exit layer between venture rounds and public listings.

Why are India secondaries funds growing now?

The macro setup is doing a lot of the work.

India’s private markets absorbed roughly $429 billion of PE-VC investment between 2014 and 2024. A big chunk of that capital is now old enough to need exits. Bain has noted that about $108 billion invested from 2014 to 2018 has crossed the decade mark, while another $177 billion from 2019 to 2021 is moving into harvest mode. That’s a lot of inventory.

At the same time, exit timelines have stretched. The median IPO age has climbed from 6.9 years to 10.7 years over the last decade. That delay leaves founders, employees, and funds holding valuable but illiquid paper for longer than they expected. Secondaries step into that gap.

There’s also a scale argument. Oister estimates India’s annual secondary opportunity could reach as much as $20 billion. That doesn’t sound crazy anymore. Bain’s 2025 private equity work showed India hit about $33 billion in exits in 2024 and became Asia-Pacific’s biggest exit market by value. In the region more broadly, secondary transactions have already become the largest exit channel by value.

And one more thing. Domestic money is getting more comfortable with private markets. That’s important because local capital tends to understand founder behavior, listing cycles, and the weird timing of Indian exits better than distant allocators do. If that comfort keeps deepening, startup secondaries could move from occasional dealmaking to a standard portfolio-management tool.

Is ACE Fund III arriving at the right time?

It probably is.

The Indian startup market has enough mature companies now, enough delayed exits, and enough investor fatigue to support specialized liquidity funds that do one thing well. ACE Fund III is really a bet that startup liquidity itself is becoming a durable asset class in India. What to watch next is deployment discipline — not just whether Oister can write cheques, but whether it can keep buying into companies that are actually close to real exits.

Read how NanoCo raised a $12M seed round led by Valley Capital Partners to build NanoClaw, a security-first AI agent platform that runs tasks inside isolated containers instead of giving agents full machine access.

FAQ

– What is the size of ACE Fund III? 

 ACE Fund III is targeting ₹500 crore, and that number includes a ₹250 crore greenshoe option. It’s Oister Global’s third dedicated secondaries vehicle, launched after ACE Fund II closed at ₹400 crore and was oversubscribed 2x.

– How does Oister Global’s secondary fund model work? 

 Oister buys existing shares in late-stage private companies from current holders instead of putting fresh money directly into the startup. That gives liquidity to sellers such as founders, employees, or early investors. New backers get exposure to businesses that are typically closer to IPOs, strategic exits, or later-stage fundraising.

– How experienced are Oister Global’s founders? 

 Oister was founded in 2022 by Rohit Bhayana and Sandeep Sinha, both of whom came into it from Lumis and years of private-market investing. Bhayana previously led GE Software Solutions, while Sinha held senior roles at 3Com Technologies and earlier worked through GE’s leadership system.

– Why are startup secondaries becoming a bigger market in India? 

 Because India now has more mature startups than it has easy exit routes. With PE-VC investments from the last decade aging, IPO timelines stretching past 10 years on median, and an estimated $20 billion annual secondary opportunity, secondaries are becoming a practical way to create liquidity without forcing a new primary round or waiting indefinitely for a listing.

NanoCo builds NanoClaw, a security-first AI agent platform that runs tasks inside isolated containers instead of giving an agent the keys to your whole machine. Its $12 million NanoClaw funding round matters because the pitch isn’t “agents are cool” — it’s that enterprises want agents they can trust with real work. Founded in early 2026 by brothers Gavriel Cohen and Lazer Cohen, the company took off after a viral open-source launch and now has backing from Valley Capital Partners, Docker, Vercel, Monday.com, Slow Ventures, and Hugging Face CEO Clem Delangue.

What is NanoClaw and how does it work?

NanoClaw is an open-source AI assistant framework that routes messages from tools like WhatsApp, Slack, Telegram, Teams, Discord, email, and the terminal into a shared agent system. It then runs the actual agent session inside a sandboxed container. By default it uses Anthropic’s Claude Agent SDK, but it also supports other providers. It keeps memory, session state, and task scheduling attached to the right conversation instead of turning everything into one giant chat blob.

The security model is the whole point. Each invocation runs in an isolated Linux container with tightly scoped mounts and a non-root user. Execution is fresh and ephemeral. On macOS, NanoClaw can use Apple Container; on Docker, it can go a step further with Docker Sandboxes and microVM-style isolation. That means bash commands, file writes, and browser actions happen away from the host machine rather than behind a flimsy in-app permission prompt.

For a user, the workflow is pretty simple. You install the core system, run setup, connect only the channels you want, and let the platform route incoming requests to the right agent context. NanoClaw then handles memory files and workspaces. It also manages logs, task scheduling, and message delivery across channels. Shared sessions are supported too, so a conversation can move between, say, chat and webhook flows without losing state.

The newer layer is approval. Through its Vercel partnership, NanoClaw can surface native approval cards inside messaging apps when an agent wants to do something sensitive. That includes sending an email, making a payment, or deleting a cloud resource. That sounds mundane. It isn’t.

Who founded NanoCo and why did they build NanoClaw?

A startup born out of an internal need

NanoCo was founded in early 2026 by brothers Gavriel Cohen and Lazer Cohen after they ran into a problem inside their previous AI marketing startup. They were already using agents to do a lot of the work, but the available tools felt too exposed. NanoClaw started as their answer: a secure alternative to OpenClaw that kept agent behavior boxed into a container instead of letting it run straight on a computer with broad access to services and credentials.

The timeline was absurdly fast. Gavriel said it took “under six weeks from committing the first lines of code to a term sheet.” Before the company existed in any formal sense, the project had gone viral, drawn praise from Andrej Karpathy, and gotten an unexpected boost when Singapore’s foreign minister described NanoClaw as his “second brain.” The brothers also turned down a six-figure early offer to buy the project, then later rejected an acquisition proposal worth roughly $20 million.

Why the brothers had real market fit

Gavriel wasn’t some tourist founder who stumbled into AI because the category got hot. He previously worked at Wix, has academic training in physics and computer science, and had been doing deep after-hours AI tinkering before NanoClaw took off. That background helps explain why the project’s core pitch is architectural, not just branding. Smaller codebase. Tighter permissions.

Lazer came from the other side of startup building. He spent years in communications and built Concrete Media into a PR firm that helped launch more than 100 startups. That’s useful here in a practical way. Open source traction doesn’t automatically become a company. Someone still has to turn attention into customers, partnerships, and a story investors can underwrite.

Early traction, customers, and the NanoClaw funding round

The open-source community gave NanoClaw its first real proof point. The brothers say the product has many thousands of users, and NanoCo has already started signing enterprise customers after community members pushed the team toward a commercial offering. The company now has 10 employees and official partnerships with Docker and Vercel.

Enterprise demand is showing up in a specific way. Technical early adopters inside large companies set up NanoClaw for themselves, then coworkers started asking for the same thing. NanoCo’s answer is to sell implementation help — what the market now calls forward-deployed engineers — so customers can roll out AI agents to employees without turning one internal enthusiast into unpaid IT support. NanoCo wouldn’t name customers, but said executives at Amazon, Gap, Google, Meta, SentinelOne, and Accenture are already using NanoClaw.

On the capital side, Valley Capital Partners led the oversubscribed round, with Docker, Vercel, Monday.com, Slow Ventures, and Clem Delangue among the backers. That investor mix is telling. It isn’t just generalist venture money chasing a meme. Two of the participants sit directly inside the infrastructure and workflow stack NanoClaw is trying to own.

How NanoClaw compares with OpenClaw and other options

OpenClaw is the obvious comparison, and NanoClaw doesn’t hide from that. The whole product exists because the brothers liked what OpenClaw made possible but didn’t like the risk profile. NanoClaw’s differentiator is less about magical new agent intelligence and more about constrained execution. Smaller code footprint. OS-level isolation. Scoped mounts and auditable logs.

There are other ways to approach the same enterprise problem. A team can stitch together Claude Code or another agent framework, add a credential vault, bolt on approvals, and run the whole thing in Docker. But that’s still custom plumbing. NanoClaw is trying to package the hard part into something opinionated enough to deploy, while staying light enough that technical buyers can still understand it.

Why did NanoCo raise now instead of selling?

Because the company saw a chance to become infrastructure, not just code.

Rejecting the buyout offers signals that. If the founders thought NanoClaw was only a clever open-source wrapper, taking the money would’ve been rational. But the next step is enterprise deployment, support, and governance — the boring stuff that turns a viral developer project into a business. The forward-deployed engineer model points straight at that.

The round also gives NanoCo a way to commercialize without wrecking the thing that made NanoClaw popular in the first place. That matters. Open-source security tools die all the time when founders bury them under enterprise bloat. NanoCo now has enough capital to hire around support, approvals, and customer rollouts while keeping the core product lean.

And the cap table matters on its own. Docker’s involvement validates the sandboxing thesis. Vercel’s involvement validates the human-approval UX layer. Those aren’t random logos.

How big is the market for secure AI agents?

The wider agent market is getting big in a hurry. Grand View Research projects the global AI agents market will reach $182.97 billion by 2033, growing at a 49.6% CAGR from 2026. That kind of forecast deserves some skepticism, but it captures the direction of travel: businesses are moving from chatbots toward software that can take actions.

The cleaner signal is adoption inside enterprise software. Gartner said 40% of enterprise applications will feature task-specific AI agents by the end of 2026, up from less than 5% in 2025. In a separate 2026 survey, Gartner said only 17% of organizations had deployed AI agents so far, but more than 60% expected to do so within 2 years. That gap tells you what startups like NanoCo are selling into. Not a mature market. An impatient one.

There’s a catch. Gartner also predicted more than 40% of agentic AI projects will be canceled by the end of 2027 because of cost, weak business value, or inadequate controls. And that’s exactly where NanoClaw is trying to wedge itself in. Not at the model layer. At the trust layer.

Final take on NanoClaw funding

NanoClaw funding is interesting because it backs a constraint, not just a capability.

A lot of agent startups are still selling the dream that software can act like an employee. NanoCo is selling the less glamorous idea that the employee needs a badge, a locked office, and a manager who can say no. That’s a much better story for enterprise buyers.

Read how Imperagen raised a £5M seed round led by PXN Ventures to speed up enzyme engineering with a platform that combines quantum simulation, AI, and robotics to reduce lab-heavy trial and error.

FAQ

– What funding did NanoCo raise for NanoClaw?  

 NanoCo raised an oversubscribed $12 million seed round in May 2026. Valley Capital Partners led the deal, and the backers included Docker, Vercel, Monday.com, Slow Ventures, and Hugging Face CEO Clem Delangue.

– How does NanoClaw work?  

 NanoClaw routes requests from chat apps and other channels into an AI agent that runs inside an isolated container instead of directly on the host machine. It adds memory and scheduled tasks. It also handles channel routing and approval workflows so an agent can do useful work without getting broad unchecked access.

– Who are the founders of NanoCo?  

 NanoCo was founded in early 2026 by brothers Gavriel Cohen and Lazer Cohen. Gavriel came from engineering roles at Wix and built NanoClaw itself, while Lazer previously built Concrete Media, a PR firm that helped launch more than 100 startups.

– Is NanoClaw part of the enterprise AI agent market?  

 Yes. NanoClaw sits inside the enterprise AI agent category, but more specifically in the security and deployment layer for agents that need to operate across business tools and communication channels. That niche is getting attention as enterprises push beyond demos and demand isolation, approvals, and governance before broader rollouts.

Imperagen is an enzyme engineering startup that uses quantum simulation, AI, and robotics to design better enzymes faster. The Manchester company raised a £5 million seed round on Thursday. PXN Ventures led the deal, while IQ Capital and Northern Gritstone also participated. The pitch is simple: enzyme engineering is still too slow and too dependent on lab-heavy trial and error. Imperagen was founded in 2021 by Dr. Andrew Currin, Dr. Tim Eyes, and Dr. Andy Almond as a spinout from the University of Manchester’s Manchester Institute of Biotechnology.

What does Imperagen’s enzyme engineering platform do?

Imperagen’s product is a closed-loop enzyme engineering system. A customer starts with an enzyme problem — maybe they need a catalyst that works faster, survives harsher process conditions, or performs a very specific chemistry. Imperagen models that reaction at quantum-physics level, uses AI to prioritize promising variants, then tests those candidates in an automated lab before feeding the results back into the model. It’s a design-build-test-learn workflow, with a much heavier emphasis on mechanistic simulation than most AI protein tools.

That matters because lots of protein-design platforms still begin with sequence guessing and then rely on big rounds of wet-lab screening to see what sticks. Imperagen is trying to cut out a lot of that blind searching. Its system explores millions of mutation combinations in silico, then narrows the field before the physical work starts. It still needs experimentation. But each cycle should be more informed and less wasteful.

The company calls the underlying stack Digital Enzyme Evolution. On the lab side, it uses high-capacity robotics that can test up to a few thousand variants in a run. That’s where the feedback loop becomes useful instead of theoretical. Data from those experiments retrains problem-specific AI models, so the system gets better as it works through a customer’s exact chemistry instead of relying only on broad protein data.

It isn’t framed as a one-enzyme niche tool. Imperagen has already evaluated compatibility across multiple enzyme classes used in pharma and industrial biocatalysis, including oxidases, reductases, transaminases, and glucosidases. For customers, the promise is less “here’s an AI model” and more “here’s a faster way to get to a production-ready biocatalyst.” That’s a stronger commercial pitch if the science holds up outside the lab.

Who founded the enzyme engineering startup Imperagen?

Founded in Manchester to fix a stubborn chemistry problem

Imperagen came out of the Manchester Institute of Biotechnology, where the founding team had been attacking enzyme design from different angles. One stream was computational — advanced models that could screen huge mutation sets. The other was experimental — better ways to build and test enzyme variants in the lab. The founding idea was that combining those two approaches would beat the old method of repeated random mutation and screening.

That origin story fits the product. A lot of biotech startups bolt AI onto an existing workflow and call it a day. Imperagen seems to have been built around the workflow from day 1.

Why this founding team fits the job

Dr. Andy Almond, now CTO and co-founder, brings the clearest startup track record. He’s a biophysicist and previously co-founded C4X Discovery, which went public in 2014. That matters because Imperagen isn’t just a research project anymore. It needs somebody who understands how to turn hard science into a company people will actually buy from.

Dr. Andrew Currin, the company’s CSO and co-founder, is the deep technical anchor. He’s an expert in directed evolution and synthetic biology. He’s also credited with the patented gene-assembly technologies behind Imperagen’s automated platform. Tim Eyes, a co-founder who now serves as director of programs, came up through protein engineering, started his career in therapeutic biotech, and held an Enterprise Fellowship at the University of Manchester. The mix is tight. Biophysics, enzyme science, and protein engineering all map directly to a company trying to industrialize biocatalysis.

Fundraising, early signals, and where Imperagen sits against rivals

PXN Ventures led the new £5 million seed round, with IQ Capital and Northern Gritstone participating, and it takes Imperagen’s total funding to £8.5 million. On the same day, the company said Guy Levy-Yurista will become CEO, while the founding scientists stay in the business. Before this round, Imperagen had already picked up a £350,000 UKRI engineering biology award in March 2024 for work on its Digital Enzyme Evolution platform. That gave the science some external validation before the new capital arrived.

Competition is real, and it’s not all the same. Cradle is building a SaaS-style protein design platform and raised $73 million in late 2024 to expand its wet lab and software reach. Biomatter has pitched a more de novo, generative approach to enzyme design and raised a €6.5 million seed round to push that model further. Absci sits in a bigger, more therapeutics-heavy category, combining AI and synthetic biology with a large wet-lab data engine for protein drug creation. Imperagen’s angle is narrower and more practical: it’s focused on industrial biocatalysis and enzyme engineering problems where mechanistic chemistry, robotics, and real manufacturing constraints matter more than flashy sequence generation alone. The legacy alternative isn’t another startup. It’s directed evolution by hand, contract labs, and long development cycles.

Why does this enzyme engineering startup funding matter?

This round matters because it looks like a shift from spinout science to company-building. Imperagen said the new money will go into hiring more AI specialists, expanding R&D, building out experimental lab capacity, and creating a go-to-market function over the next 2 years. This isn’t a keep-the-lights-on raise. It’s a build-the-machine raise.

The CEO hire is part of that. Levy-Yurista comes in with a background across AI, life sciences, and enterprise technology, and his brief isn’t subtle: build a vertical AI infrastructure for biocatalysis, sharpen commercial models, and add industrial partnerships. Investors aren’t just betting on better models. They’re betting on a company that can package those models into a repeatable product.

His framing is also more grounded than a lot of biotech AI talk. He’s argued that many AI-led enzyme tools can beat trial-and-error in theory but still fail when pushed to industrial scale in practice. So the pitch here isn’t magic. It’s to make enzyme development “faster, more reliable, and more commercially accessible,” helping companies bring bio-based products to market without the usual delay and uncertainty.

How big is the market for AI enzyme engineering?

The commercial backdrop is big enough to get investor attention. Grand View Research estimated the global engineered enzymes market at $2.78 billion in 2024 and projects it to reach $7.32 billion by 2033, which implies an 11.6% CAGR. In the U.S. alone, the broader enzymes market was estimated at $3.8 billion in 2023, with projected annual growth of 6.7% through 2030.

The demand drivers are pretty clear. Pharma needs more selective catalysts for drug manufacturing. Food and agriculture keep looking for cleaner processing tools. Industrial chemistry is under pressure to lower energy use and swap out harsher reaction conditions where it can. Enzymes sit right in the middle of that shift, which is why so many techbio companies are piling into protein design right now. The hard part isn’t explaining why the market exists. It’s proving a platform can deliver enzymes that survive real production environments, not just elegant demos.

Can Imperagen turn enzyme engineering into software?

That’s the bet.

Imperagen has the ingredients investors usually want in a deep-tech biotech company: scientific depth, a founder team with domain credibility, a new CEO brought in for commercial scale, and a product story that goes beyond generic “AI for biology” claims. But this category is unforgiving. If the company can show that its closed-loop platform consistently produces enzymes that work on industrial timelines and economics, this enzyme engineering startup could become one of the more interesting biocatalysis companies to watch over the next 24 months.

Read how Stilta raised a $10.5M seed led by Andreessen Horowitz to automate the repetitive research and analysis behind patent litigation with AI agents that generate claim charts, prior art searches, and case-ready legal reports.

FAQ

– What funding did Imperagen raise? Imperagen raised a £5 million seed round announced on Thursday. PXN Ventures led the deal, and IQ Capital plus Northern Gritstone joined in. The raise brings the company’s total funding to £8.5 million and is meant to support hiring, R&D, lab expansion, and commercial buildout.

– How does Imperagen’s platform work? It works as a closed-loop enzyme engineering system that combines quantum-level simulation, AI ranking, and robotic lab testing. Instead of mutating enzymes mostly by trial and error, Imperagen models likely outcomes on a computer first, tests the best candidates in the lab, and feeds that experimental data back into the model for the next round.

– Who founded Imperagen? Imperagen was founded in 2021 by Dr. Andrew Currin, Dr. Tim Eyes, and Dr. Andy Almond, all scientists tied to the Manchester Institute of Biotechnology. Their backgrounds span directed evolution, protein engineering, synthetic biology, and biotech company creation, which is why the founding team looks credible for this very specific problem.

– What market is Imperagen in? Imperagen sits in enzyme engineering and industrial biocatalysis, with overlap into techbio and AI-driven protein design. Its target customers are companies using enzymes in pharmaceuticals, food, biofuels, agriculture, and other manufacturing workflows where better catalysts can cut time, cost, and process complexity.